In last trading session, Candel Therapeutics Inc (NASDAQ:CADL) saw 12.07 million shares changing hands with its beta currently measuring -1.05. Company’s recent per share price
In recent trading session, Candel Therapeutics Inc (NASDAQ:CADL) saw 1.71 million shares changing hands at last check today with its beta currently measuring -1.05. Company’s
Candel Therapeutics Inc (NASDAQ:CADL) has a beta value of -0.96 and has seen 8.05 million shares traded in the last trading session. The company, currently
Candel Therapeutics Inc (NASDAQ:CADL) has a beta value of -1.00 and has seen 18.61 million shares traded in the last trading session. The company, currently
During the last session, Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares were 100.48 million, with the beta value of the company hitting -0.93. At the end
In today’s recent session, 52.63 million shares of the Candel Therapeutics Inc (NASDAQ:CADL) have been traded, and its beta is -0.93. Most recently the company’s
Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares stood at 0.61 million during the last session, with the company’s beta value hitting -0.94. At the close of
In last trading session, Candel Therapeutics Inc (NASDAQ:CADL) saw 0.61 million shares changing hands with its beta currently measuring -0.91. Company’s recent per share price
Candel Therapeutics Inc (NASDAQ:CADL) has a beta value of -0.96 and has seen 2.3 million shares traded in the last trading session. The company, currently
In last trading session, Candel Therapeutics Inc (NASDAQ:CADL) saw 0.42 million shares changing hands with its beta currently measuring -0.90. Company’s recent per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
